Abstract:This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record. This version will undergo additional copyediting, typesetting and review before it is published in its final form, but we are providing this version to give early visibility of the article. Please note that, during the production process, errors may be discovered which could affect the content, a… Show more
“…GDNF is a protein distributed in the gastrointestinal tract that modulates the growth and development of nerve cells (Allen, Watson, Shoemark, Barua, & Patel, 2013), repairs damaged nerve fibers, as well as promotes intestinal epithelial cell proliferation (Kalff, Schraut, Billiar, Simmons, & Bauer, 2000) and repairs the damaged intestinal tract (Su et al, 2019). As shown in Figure 3, the mRNA expression of GDNF in model mice was significantly inhibited by montmorillonite-induced constipation.…”
Section: Discussionmentioning
confidence: 99%
“…The interstitial cells of Cajal (ICC) are nerve-like cells at the ends of motor neurons that maintained by c-Kit, which promotes intestinal motility in the gastrointestinal system (Bansil & Turner, 2018;Lee, Park, Kamm, & Talbot, 2005;Yu, Crowell, Tihan, & Lacy, 2002). Low levels of ICC can be observed in patients with constipation (Sabri, Barksdale, & Lorenzo, 2003;Su et al, 2019). LAB could improve constipation by upregulating the expression of c-Kit mRNA (Chen et al, 2020).…”
Section: Discussionmentioning
confidence: 99%
“…Transient receptor potential cation channel subfamily V member 1 (TRPV1), a member of the TRPV group of transient receptor potential family of ion channels, is associated with the release of SP and closely related to defecation (Geppetti & Trevisani, 2004;Peng & Li, 2010), and its overexpression might indicate intestinal injury (Su et al, 2019). Treatment with LP-KSFY06 reduced the increased expression level of TRPV1 to some degree, while the combination of LP-KSFY06 and geniposide nearly eliminated the increased expression of TRPV1 in a manner similar to that in normal mice.…”
Section: Discussionmentioning
confidence: 99%
“…However, a mass of NO derived from iNOS under inflammatory reaction will suppress the contractility of intestinal smooth muscle (Moojen et al, 1999;Toda & Okamura, 2016). Moreover, prostaglandin released by cyclooxygenase-2 (COX-2) also inhibits the intestinal smooth muscle contractility (Schwarz et al, 2001;Su et al, 2019). Inhibition of the expression of either iNOS or COX-2 can significantly enhance the motility of the small intestine (Wen et al, 2006).…”
Constipation is a common clinical manifestation of digestive system disorders and occurs worldwide. This study investigated the ability of Lactobacillus plantarum KSFY06 (LP‐KSFY06) to promote the action of geniposide in preventing montmorillonite‐induced constipation in Kunming mice, with the aim of providing a successful solution. The effects of LP‐KSFY06 and geniposide on constipation were measured, and the results showed that the protective effect of geniposide on constipation was enhanced by LP‐KSFY06 and that the combination resulted in increased weight, moisture content, and particle number of feces. The first black stool defecation time was decreased from 182 min to 87 min, which clearly indicates that defecating difficulty was alleviated in constipated mice. The synergic intervention of LP‐KSFY06 and geniposide (LP + G) assisted in maintaining the body weight of constipated mice. The LP + G intervention significantly increased serum levels of motilin (MTL, 167.8 pg/ml), acetylcholinesterase (AChE, 45.3 pg/ml), substance P (SP, 61.0 pg/ml), vasoactive intestinal peptide (VIP, 70.5 pg/ml), endothelin‐1 (ET‐1, 16.1 pg/ml), and gastrin (73.0 pg/ml) and remarkably decreased somatostatin (SS, 35.2 pg/ml) when compared to those indexes in the LP‐KSFY06 group and geniposide group. The LP + G treatment also significantly increased the mRNA expression of cluster of differentiation 117 (c‐Kit), stem cell factor (SCF), glial cell‐derived neurotrophic factor (GDNF), and remarkably downregulated the expression of inducible nitric oxide synthase (iNOS), transient receptor potential vanilloid‐1 (TRPV1), and cyclooxygenase‐2 (COX‐2). The experimental results showed that the combination treatment has the strongest prevention effect against constipation, and LP‐KSFY06 promotes the ability of geniposide to prevent constipation. Therefore, LP‐KSFY06 is a potential probiotic strain with the capacity to prevent montmorillonite‐induced constipation.
“…GDNF is a protein distributed in the gastrointestinal tract that modulates the growth and development of nerve cells (Allen, Watson, Shoemark, Barua, & Patel, 2013), repairs damaged nerve fibers, as well as promotes intestinal epithelial cell proliferation (Kalff, Schraut, Billiar, Simmons, & Bauer, 2000) and repairs the damaged intestinal tract (Su et al, 2019). As shown in Figure 3, the mRNA expression of GDNF in model mice was significantly inhibited by montmorillonite-induced constipation.…”
Section: Discussionmentioning
confidence: 99%
“…The interstitial cells of Cajal (ICC) are nerve-like cells at the ends of motor neurons that maintained by c-Kit, which promotes intestinal motility in the gastrointestinal system (Bansil & Turner, 2018;Lee, Park, Kamm, & Talbot, 2005;Yu, Crowell, Tihan, & Lacy, 2002). Low levels of ICC can be observed in patients with constipation (Sabri, Barksdale, & Lorenzo, 2003;Su et al, 2019). LAB could improve constipation by upregulating the expression of c-Kit mRNA (Chen et al, 2020).…”
Section: Discussionmentioning
confidence: 99%
“…Transient receptor potential cation channel subfamily V member 1 (TRPV1), a member of the TRPV group of transient receptor potential family of ion channels, is associated with the release of SP and closely related to defecation (Geppetti & Trevisani, 2004;Peng & Li, 2010), and its overexpression might indicate intestinal injury (Su et al, 2019). Treatment with LP-KSFY06 reduced the increased expression level of TRPV1 to some degree, while the combination of LP-KSFY06 and geniposide nearly eliminated the increased expression of TRPV1 in a manner similar to that in normal mice.…”
Section: Discussionmentioning
confidence: 99%
“…However, a mass of NO derived from iNOS under inflammatory reaction will suppress the contractility of intestinal smooth muscle (Moojen et al, 1999;Toda & Okamura, 2016). Moreover, prostaglandin released by cyclooxygenase-2 (COX-2) also inhibits the intestinal smooth muscle contractility (Schwarz et al, 2001;Su et al, 2019). Inhibition of the expression of either iNOS or COX-2 can significantly enhance the motility of the small intestine (Wen et al, 2006).…”
Constipation is a common clinical manifestation of digestive system disorders and occurs worldwide. This study investigated the ability of Lactobacillus plantarum KSFY06 (LP‐KSFY06) to promote the action of geniposide in preventing montmorillonite‐induced constipation in Kunming mice, with the aim of providing a successful solution. The effects of LP‐KSFY06 and geniposide on constipation were measured, and the results showed that the protective effect of geniposide on constipation was enhanced by LP‐KSFY06 and that the combination resulted in increased weight, moisture content, and particle number of feces. The first black stool defecation time was decreased from 182 min to 87 min, which clearly indicates that defecating difficulty was alleviated in constipated mice. The synergic intervention of LP‐KSFY06 and geniposide (LP + G) assisted in maintaining the body weight of constipated mice. The LP + G intervention significantly increased serum levels of motilin (MTL, 167.8 pg/ml), acetylcholinesterase (AChE, 45.3 pg/ml), substance P (SP, 61.0 pg/ml), vasoactive intestinal peptide (VIP, 70.5 pg/ml), endothelin‐1 (ET‐1, 16.1 pg/ml), and gastrin (73.0 pg/ml) and remarkably decreased somatostatin (SS, 35.2 pg/ml) when compared to those indexes in the LP‐KSFY06 group and geniposide group. The LP + G treatment also significantly increased the mRNA expression of cluster of differentiation 117 (c‐Kit), stem cell factor (SCF), glial cell‐derived neurotrophic factor (GDNF), and remarkably downregulated the expression of inducible nitric oxide synthase (iNOS), transient receptor potential vanilloid‐1 (TRPV1), and cyclooxygenase‐2 (COX‐2). The experimental results showed that the combination treatment has the strongest prevention effect against constipation, and LP‐KSFY06 promotes the ability of geniposide to prevent constipation. Therefore, LP‐KSFY06 is a potential probiotic strain with the capacity to prevent montmorillonite‐induced constipation.
“…Studies have conrmed that more severe degrees of constipation signicantly reduce the fecal quantity, weight, water content, time to discharge the rst black stool, and the activated carbon propulsion rate in experimentally constipated mice. 28,29 In this study, KFY02 in combination with gardenoside inhibited the effects of constipation in mice. KFY02 and gardenoside significantly reduced the body weight, fecal water content, time of the rst defecation and propellant speed of activated carbon in constipated mice.…”
Lactobacillus plantarum KFY02 (KFY02), isolated from naturally fermented milk yoghurt in Korla, Xinjiang, Northwest of China, showed gardenoside action for the intestinal regulation of constipated mice.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.